ArticleScientific reports2026
DeepRetro discovers retrosynthetic pathways through iterative large language model reasoning.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Synthesizing complex natural products is a grand challenge in organic chemistry. We present DeepRetro, a significant advancement in computational retrosynthesis that discovers viable synthetic routes for molecules previously considered too complex for automated methods. DeepRetro is a novel, open-source framework that tightly integrates large language models (LLMs), traditional retrosynthetic engines, and expert human feedback into an iterative design loop. Unlike prior approaches that rely on either template-based methods or unconstrained LLMs, our hybrid system combines the precision of templates with the generative flexibility of LLMs, governed by rigorous chemical validity checks and recursive refinement. This system dynamically explores and revises synthetic pathways, guided by algorithmic checks and expert input through an interactive interface. While DeepRetro shows strong performance on standard benchmarks, its main strength is its ability to propose novel, viable pathways for highly complex natural products. Through case studies, we demonstrate how this approach facilitates new total synthesis routes and enhances human-machine collaboration. DeepRetro serves as a working model for applying LLMs to scientific discovery, and we release it as an open-source tool to accelerate progress in drug discovery and materials design.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.